Literature DB >> 8882644

A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients.

P N Nelson1, B K Rawal, Y S Boriskin, K E Mathers, R L Powles, H M Steel, Y S Tryhorn, P D Butcher, J C Booth.   

Abstract

A reverse transcription (RT) nested polymerase chain reaction (PCR) procedure is described for detecting RNA to a spliced late gene (SLG) of human cytomegalovirus (CMV), the product of which (175 bp) is easily differentiated in agarose gels from the product when the target is unspliced viral RNA or DNA (258 bp). The SLG-RT-PCR has been compared against a semi-quantitative PCR for CMV DNA in buffy-coat specimens collected weekly after bone marrow transplantation from 3 patients and against the results of culturing these specimens for CMV both by conventional virus isolation, based on the detection of cytopathic effect, and by the early detection of infected cells by staining with virus-specific monoclonal antibodies. The detection of CMV RNA by SLG-RT-PCR correlated well with the detection of infective virus but only when the results of both culture methods were combined, in that neither culture method alone was as sensitive as the SLG-RT-PCR. The presence of SLG RNA in the circulation is of value as a marker of active CMV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882644     DOI: 10.1016/0166-0934(95)01900-6

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

Review 1.  Demystified ... the polymerase chain reaction.

Authors:  K R Baumforth; P N Nelson; J E Digby; J D O'Neil; P G Murray
Journal:  Mol Pathol       Date:  1999-02

2.  Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

Authors:  G Gerna; E Percivalle; F Baldanti; S Sozzani; P Lanzarini; E Genini; D Lilleri; M G Revello
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.

Authors:  M J Blok; I Lautenschlager; V J Goossens; J M Middeldorp; C Vink; K Höckerstedt; C A Bruggeman
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.

Authors:  A E Greijer; E A Verschuuren; M C Harmsen; C A Dekkers; H M Adriaanse; T H The; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.

Authors:  G Gerna; F Baldanti; D Lilleri; M Parea; E Alessandrino; A Pagani; F Locatelli; J Middeldorp; M G Revello
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

Authors:  G Gerna; F Baldanti; J M Middeldorp; M Furione; M Zavattoni; D Lilleri; M G Revello
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

7.  Evaluation of two set of primers for detection of immediate early gene UL123 of human cytomegalovirus (HCMV).

Authors:  Massimiliano Bergallo; Cristina Costa; Maria Elena Terlizzi; Samuela Margio; Francesca Sidoti; Franca Sinesi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-08-25       Impact factor: 2.695

8.  Reverse transcriptase-polymerase chain reaction to evaluate human cytomegalovirus lytic gene expression.

Authors:  Massimiliano Bergallo; Cristina Costa; Maria Elena Terlizzi; Samuela Margio; Francesca Sidoti; Sara Astegiano; Franca Sinesi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2008-05-31       Impact factor: 2.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.